Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ling Wan

Showing results (141-150 of 176) with videos related to

Pageof 18
Sort By:
Neuroscience Letters|January 13, 2006
Association between the brain-derived neurotrophic factor (BDNF) gene and schizophrenia in the Chinese populationQing-Ying Chen, Qi Chen, Guo-Yin Feng, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 30, 2013
HER2-specific T lymphocytes kill both trastuzumab-resistant and trastuzumab-sensitive breast cell lines in vitroXiao-Lin Lin, Xiao-Li Wang, Bo Ma, et al.
Biochemical Pharmacology|July 11, 2021
miR-19a-3p downregulates tissue factor and functions as a potential therapeutic target for sepsis-induced disseminated intravascular coagulationRong Zhang, Sifen Lu, Xudan Yang, et al.
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology|August 5, 2003
[Clinical research of the implantation of phakic anterior chamber intraocular lens for high myopia]Ke Yao, Wen Xu, Jian-chun Yu, et al.
Frontiers in Pharmacology|November 29, 2024
Corrigendum: Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancerHui-Wen Yang, Yan Lan, An Li, et al.
Frontiers in Pharmacology|November 29, 2023
Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancerHui-Wen Yang, Yan Lan, An Li, et al.
Frontiers in Immunology|May 5, 2023
Case Report: Blinatumomab therapy for the treatment of B-cell acute lymphoblastic leukemia patients with central nervous system infiltrationHan-Yu Cao, Hui Chen, Song-Bai Liu, et al.
Annals of Hematology|April 27, 2023
Rapid molecular response to dasatinib in Ph-like acute lymphoblastic leukemia patients with ABL1 rearrangements: case series and literature reviewKai-Wen Tan, Yi-Yan Zhu, Qiao-Cheng Qiu, et al.
Clinical Case Reports|December 12, 2023
Preemptive inotuzumab ozogamicin eradicated measurable residual disease in Ph-negative acute lymphoblastic leukemia relapsed post CD19 CART therapySi-Man Huang, Chao-Ling Wan, Han-Yu Cao, et al.
Annals of Hematology|December 12, 2024
Chidamide combined with azacitidine as a novel double epigenetic preemptive treatment for a myelodysplastic syndrome patient showing molecular relapse after allogeneic hematopoietic stem cell transplantationFang-Tong Liu, Chao-Ling Wan, Yuan-Hong Huang, et al.
Pageof 18

Showing results (141-150 of 176) with videos related to

Sort By:
Pageof 18
Neuroscience Letters|January 13, 2006
Association between the brain-derived neurotrophic factor (BDNF) gene and schizophrenia in the Chinese populationQing-Ying Chen, Qi Chen, Guo-Yin Feng, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 30, 2013
HER2-specific T lymphocytes kill both trastuzumab-resistant and trastuzumab-sensitive breast cell lines in vitroXiao-Lin Lin, Xiao-Li Wang, Bo Ma, et al.
Biochemical Pharmacology|July 11, 2021
miR-19a-3p downregulates tissue factor and functions as a potential therapeutic target for sepsis-induced disseminated intravascular coagulationRong Zhang, Sifen Lu, Xudan Yang, et al.
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology|August 5, 2003
[Clinical research of the implantation of phakic anterior chamber intraocular lens for high myopia]Ke Yao, Wen Xu, Jian-chun Yu, et al.
Frontiers in Pharmacology|November 29, 2024
Corrigendum: Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancerHui-Wen Yang, Yan Lan, An Li, et al.
Frontiers in Pharmacology|November 29, 2023
Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancerHui-Wen Yang, Yan Lan, An Li, et al.
Frontiers in Immunology|May 5, 2023
Case Report: Blinatumomab therapy for the treatment of B-cell acute lymphoblastic leukemia patients with central nervous system infiltrationHan-Yu Cao, Hui Chen, Song-Bai Liu, et al.
Annals of Hematology|April 27, 2023
Rapid molecular response to dasatinib in Ph-like acute lymphoblastic leukemia patients with ABL1 rearrangements: case series and literature reviewKai-Wen Tan, Yi-Yan Zhu, Qiao-Cheng Qiu, et al.
Clinical Case Reports|December 12, 2023
Preemptive inotuzumab ozogamicin eradicated measurable residual disease in Ph-negative acute lymphoblastic leukemia relapsed post CD19 CART therapySi-Man Huang, Chao-Ling Wan, Han-Yu Cao, et al.
Annals of Hematology|December 12, 2024
Chidamide combined with azacitidine as a novel double epigenetic preemptive treatment for a myelodysplastic syndrome patient showing molecular relapse after allogeneic hematopoietic stem cell transplantationFang-Tong Liu, Chao-Ling Wan, Yuan-Hong Huang, et al.
Pageof 18